According to a new study, regular prostate cancer screening does not mean that the patient will live longer.
Many federal experts and medical associations say that screening of prostate cancer in men should be stopped after the age of 75. They also mention that not enough evidences are available to make sweeping recommendations for younger people. It is found that several U. S. doctors still conduct the screening test for this disease.
In the new study, it was found that screening only diagnosed 20 cases of prostate cancer out of every 1,000 men, but there was no change in the overall death rates.
Dr. Philipp Dahm, the leading researcher of the study, said that the 20 diagnosed men would come under the 'overdiagnosed’ category.
It is worth mentioning that prostate cancer is more prevalent than breast cancer. Also, the risk of death is same as that by breast cancer.
In breast cancer, there are specific screening tests and treatment, whereas in prostate cancer the patients find it difficult to choose the treatment options.
Patrick Walsh, who is the Professor of Urology at Johns Hopkins Hospital, says that men who are detected with prostate cancer should always consult their doctors and ask whether active monitoring is required or not.